Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease
Clinical trial NCT05014555 · UNKNOWN
Trial details
- NCT number
- NCT05014555
- Sponsor
- GI Alliance
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-05
- Primary completion
- 2024-01-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.